Skip to main content

Pharmala Biotech Holdings Inc.(MDMA-CN)
CSE

Today's Change
Delayed Last Update

PharmAla appoints Dr. Leah Mayo to Scientific Advisory Board

Newswire.ca - Thu Oct 13, 2022

Dr. Mayo is the Parker Chair in Psychedelics Research at the University of Calgary; Will advise PharmAla on clinical trial design and execution

VANCOUVER, BC, Oct. 13, 2022 /CNW/ - PharmAla Biotech (CSE: MDMA) is excited to welcome Dr. Leah Mayo to the company's Scientific Advisory Board. Dr. Mayo recently took up the role of Parker Chair in Psychedelics Research at the Department of Psychiatry, the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research and Education at the University Calgary. Prior to her appointment, Dr. Mayo was Assistant Professor at the Center for Social and Affective Neuroscience, Linköping University (Sweden).

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe